Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asthma Therapeutics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102477000A details a streamlined 5-step synthesis for beta-2 agonists, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Solve low yield and toxic reagent issues in zafirlukast intermediate production. 91.6% yield, eco-friendly process, and scalable CDMO solutions for pharma R&D and procurement.